RxDoctor Payments Data

Atul Bhatia, MD

Clinical Cardiac Electrophysiology · Milwaukee, WINPI 1962479527

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 3 manufacturers reported payments, led by Abbott at 58.5% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in WI, where the typical reported total is $7,576.

$209in general payments, 2019–2025

Across 5 payments — averaging $41.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$122
  • Penumbra, Inc.$70
  • GE HealthCare$17
$45,247in research payments, 2019–2025

Across 19 payments — averaging $2381.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$45K

What the payments were for

  • Food & beverage$209100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott3$122
Penumbra, Inc.1$70
GE HealthCare1$17

How this compares

$209 in reported general payments places this provider in the 5th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.

See all clinical cardiac electrophysiology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$300,792
Medicare patients
1,764
Services billed
5,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,831$2,030,009
XareltoRivaroxaban352$444,781
MultaqDronedarone Hcl69$91,020
Dofetilide626$87,335
Metoprolol Succinate1,818$26,969
Flecainide Acetate527$26,315
Mexiletine Hcl113$13,833
EntrestoSacubitril/Valsartan11$11,589
Quinidine Sulfate20$10,761
Diltiazem 24hr Er (Cd)Diltiazem Hcl262$8,313
SotalolSotalol Hcl239$6,310
Amiodarone Hcl434$5,547
Digoxin90$4,141
Dabigatran EtexilateDabigatran Etexilate Mesylate11$3,213
Carvedilol255$2,546

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →